Real-world evidence and AI: How EHR data is reshaping drug development decisions
• AI tools utilizing Natural Language Processing (NLP) and Machine Learning (ML) are transitioning from pilot projects to routine use in drug development. • These technologies extract structured clinical data from unstructured Electronic Health Record (EHR) text, such as pathology reports and physician notes. • This shift allows sponsors and regulators to enhance research processes, specifically improving trial design and safety surveillance.
drugdiscoverynews.com

